Extract from the Register of European Patents

EP About this file: EP3912624

EP3912624 - COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  23.11.2021
Database last updated on 28.03.2026
FormerThe application has been published
Status updated on  22.10.2021
Most recent event   Tooltip23.11.2021Withdrawal of applicationpublished on 08.12.2021  [2021/49]
Applicant(s)For all designated states
Virtexx
115 Rue des Hetres
69400 Arnas / FR
[2021/47]
Inventor(s)01 / GARNIER, Patrice
30125 VENEZIA / IT
02 / SALOME, Marc
31320 MERVILLA / FR
03 / DANCHIN, Antoine
75003 PARIS / FR
 [2021/47]
Representative(s)Vial, Lionel, et al
Bardehle Pagenberg SPE SAS
SO Square Opéra
5, rue Boudreau
75009 Paris / FR
[2021/47]
Application number, filing date20175287.018.05.2020
[2021/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3912624
Date:24.11.2021
Language:EN
[2021/47]
Search report(s)(Supplementary) European search report - dispatched on:EP22.10.2020
ClassificationIPC:A61K31/397, A61K31/4706, A61K31/7052, A61K31/706, A61P31/14
[2021/47]
CPC:
A61P31/14 (EP); A61K31/397 (EP); A61K31/4706 (EP);
A61K31/7052 (EP); A61K31/706 (EP)
C-Set:
A61K31/397, A61K2300/00 (EP);
A61K31/4706, A61K2300/00 (EP);
A61K31/7052, A61K2300/00 (EP);
A61K31/706, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON UMHÜLLTEN VIRENINFEKTIONEN[2021/47]
English:COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS[2021/47]
French:COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT D'INFECTIONS DUES À DES VIRUS À ENVELOPPE[2021/47]
Examination procedure29.10.2021Application withdrawn by applicant  [2021/49]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X] WO2010027951  (UNIV ILLINOIS et al.)
 [X] GB2562691  (REHAB ALJAMAL NAYLOR et al.)
 [X]   ALEKSANDR IANEVSKI ET AL: "Novel activities of safe-in-human broad-spectrum antiviral agents", ANTIVIRAL RESEARCH, vol. 154, 1 June 2018 (2018-06-01), NL, pages 174 - 182, XP055641662, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2018.04.016

DOI:   http://dx.doi.org/10.1016/j.antiviral.2018.04.016
 [X]   OSUNA-RAMOS JUAN FIDEL ET AL: "Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 160, 1 November 2018 (2018-11-01), pages 151 - 164, XP085534508, ISSN: 0166-3542, DOI: 10.1016/J.ANTIVIRAL.2018.10.024

DOI:   http://dx.doi.org/10.1016/j.antiviral.2018.10.024
 [X]   STEPHEN STURLEY ET AL: "Insights into the COVID-19 pandemic from a rare neurodegenerative disease", 25 March 2020 (2020-03-25), XP055739605, Retrieved from the Internet [retrieved on 20201013], DOI: 10.31219/osf.io/92f3s

DOI:   http://dx.doi.org/10.31219/osf.io/92f3s
 [X]   MANLI WANG ET AL: "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", CELL RESEARCH, 4 February 2020 (2020-02-04), GB, CN, XP055672526, ISSN: 1001-0602, DOI: 10.1038/s41422-020-0282-0 [X] 1,9 * See section 3.2; page 179, column 2, paragraph 2; table 1 *

DOI:   http://dx.doi.org/10.1038/s41422-020-0282-0
by applicant  WANG ET AL., LANCET, 2020
   FUK-WOO CHAN ET AL., EMERGING MICROBES & INFECTIONS, vol. 9, 2020, pages 221 - 236
   WANG ET AL., CELL RESEARCH, vol. 30, 2020, pages 269 - 271
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.